Mirum Pharmaceuticals (MIRM) Non-cash Items (2019 - 2023)

Mirum Pharmaceuticals' Non-cash Items history runs 5 years deep, the most recent figure standing at $48.5 million for Q4 2023.

• In Q4 2023, Non-cash Items fell 6.09% year-over-year to $48.5 million; the TTM figure through Dec 2023 stood at $48.5 million (down 6.09% YoY), while the FY2023 annual figure was $48.5 million, down 6.09% from the prior year.
• Non-cash Items was $48.5 million for Q4 2023 at Mirum Pharmaceuticals, down from $152.6 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $152.6 million in Q3 2023 to a low of $23.2 million in Q3 2019.
• Historically, Non-cash Items has averaged $51.9 million across 5 years, with a median of $48.5 million in 2023.
• The sharpest annual moves came in 2020 and 2023: Non-cash Items tumbled 37.72% in 2020, then soared 233.24% in 2023.
• A 5-year view of Non-cash Items shows it stood at $65.2 million in 2019, then sank by 37.72% to $40.6 million in 2020, then fell by 19.67% to $32.6 million in 2021, then surged by 58.24% to $51.6 million in 2022, then declined by 6.09% to $48.5 million in 2023.
• The last three Non-cash Items figures came in at $48.5 million (Q4 2023), $152.6 million (Q3 2023), and $51.4 million (Q2 2023), per Business Quant data.